Back
NovaBay Pharmaceuticals, Inc. Vs. Novanta, Inc. Industry Stock Comparison
Buy
84
NBY
NovaBay Pharmaceuticals, Inc.
Last Price:
$9.49
Seasonality Move:
13.91%
Buy
52
NOVT
Novanta, Inc.
Last Price:
$128.71
Seasonality Move:
13.22%
Buy
84
NovaBay Pharmaceuticals, Inc. (NBY)
is a Buy
Is NovaBay Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals, Inc. [NBY] share price is $9.46. The Score for NBY is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
-
NBY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
52
Novanta, Inc. (NOVT)
is a Buy
Is Novanta, Inc. a Buy, Sell or Hold?
-
The current Novanta, Inc. [NOVT] share price is $128.70. The Score for NOVT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
NOVT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals, Inc.'s stock price today?
-
The NovaBay Pharmaceuticals, Inc. share price today is $9.46Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight selling pressure.
NOVT Stock Price Chart
What is Novanta, Inc.'s stock price today?
-
The Novanta, Inc. share price today is $128.70Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NOVT is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.8 | Buy |
| Relative Strength Index (14 RSI): | 75.95 | Buy |
| Chaikin Money Flow: | -303689 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.63 - 6.69) | Buy |
| Bollinger Bands (100): | (0.33 - 3.97) | Buy |
NOVT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.37 | Buy |
| Relative Strength Index (14 RSI): | 63.7 | Buy |
| Chaikin Money Flow: | 439249 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (115.87 - 123.49) | Buy |
| Bollinger Bands (100): | (105.66 - 122.64) | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.97 | Buy |
| 20-day SMA: | 4.9 | Buy |
| 50-day SMA: | 2.62 | Buy |
| 200-day SMA: | 1.37 | Buy |
| 8-day EMA: | 7.47 | Buy |
| 20-day EMA: | 5.43 | Buy |
| 50-day EMA: | 3.39 | Buy |
| 200-day EMA: | 1.26 | Buy |
NOVT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 121.8 | Buy |
| 20-day SMA: | 120.83 | Buy |
| 50-day SMA: | 116.87 | Buy |
| 200-day SMA: | 118.71 | Buy |
| 8-day EMA: | 122.72 | Buy |
| 20-day EMA: | 120.34 | Buy |
| 50-day EMA: | 117.28 | Buy |
| 200-day EMA: | 122.61 | Buy |
NovaBay Pharmaceuticals, Inc. Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and a decrease next year of $0.00 per share.
Novanta, Inc. Earnings Growth & NOVT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $0.45 per share.
NovaBay Pharmaceuticals, Inc. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novanta, Inc. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||